Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13980536 | 0.78 | — | — | |
| SCHEMBL4889194 | 0.78 | — | — | |
| SCHEMBL16626761 | 0.76 | GAA (0.43) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL20237234 | 0.76 | GAA (0.43) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| Tempol Hydroxylamine SCHEMBL8358933 | 0.74 | GAA (0.46) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL8739077 | 0.73 | — | — | |
| SCHEMBL12500630 | 0.73 | GAA (0.50) | GAAL3MBTL1 | |
| SCHEMBL13252529 | 0.73 | GAA (0.50) | GAAL3MBTL1 | |
| SCHEMBL9063734 | 0.73 | GAA (0.36) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL19937418 | 0.72 | GAA (0.30) | GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11207343-B2 | Compositions and therapeutic methods | AYUVIS RESEARCH, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-9243072-B2 | Cellulose interpolymers and method of oxidation | EASTMAN CHEMICAL COMPANY (US) | 2016-01-26 | — | — | US | disclosed |
| US-9150665-B2 | Cellulose interpolymers and method of oxidation | EASTMAN CHEMICAL COMPANY (US) | 2015-10-06 | — | — | US | disclosed |
| US-9040684-B2 | Cellulose interpolymers and method of oxidation | EASTMAN CHEMICAL COMPANY (US) | 2015-05-26 | — | — | US | disclosed |
| US-9040683-B2 | Cellulose interpolymers and method of oxidation | EASTMAN CHEMICAL COMPANY (US) | 2015-05-26 | — | — | US | disclosed |
| US-9040685-B2 | Cellulose interpolymers and method of oxidation | EASTMAN CHEMICAL COMPANY (US) | 2015-05-26 | — | — | US | disclosed |
| US-8816066-B2 | Cellulose interpolymers and methods of oxidation | EASTMAN CHEMICAL COMPANY (US) | 2014-08-26 | — | — | US | disclosed |
| CN-102906176-B | Curing liquids | OMG ADDITIVES LTD | 2014-01-01 | — | — | CN | disclosed |
| US-20130310379-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | CONSTELLATION PHARMACEUTICALS (US) | 2013-11-21 | — | — | US | disclosed |
| CN-102906176-A | Curing liquids | OMG ADDITIVES LTD | 2013-01-30 | — | — | CN | disclosed |
| CN-1922271-B | Method for preparing unsaturated polyester resins or vinyl ester resin compositions comprising phenol inhibitor | DSM IP ASSETS BV | 2011-06-01 | — | — | CN | disclosed |
| CN-101627080-A | Pre-accelerated resin composition | DSM IP ASSETS BV | 2010-01-13 | — | — | CN | disclosed |
| CN-100475908-C | Method for preparing unsaturated polyester resins or vinyl ester resin compositions comprising hydroxybenzene inhibitor | DSM IP ASSETS BV (NL) | 2009-04-08 | — | — | CN | disclosed |
| CN-101193959-A | Unsaturated polyester resin or vinyl ester resin composition | DSM IP ASSETS BV (NL) | 2008-06-04 | — | — | CN | disclosed |
| US-20080075883-A1 | PROCESS FOR PRODUCING MOLDED PRINTED MATERIAL, AND MOLDED PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| CN-1922271-A | Unsaturated polyester resins or vinyl ester resin compositions | DSM IP ASSETS BV (NL) | 2007-02-28 | — | — | CN | disclosed |
| CN-1922272-A | Unsaturated polyester resins or vinyl ester resin compositions | DSM IP ASSETS BV (NL) | 2007-02-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11207343-B2 | Compositions and therapeutic methods | RB1, TNF, FLT1 | GAA 1224/4885L3MBTL1 3218/4885KDM4E 2476/4885 |
| US-20130310379-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | TET1, TET3, EHMT2 | GAA 748/4885L3MBTL1 925/4885KDM4E 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.